Sunshine Biopharma (SBFM) News and press releases

10 Most-Searched Tickers On Benzinga Pro In April: Musk Mania, Apple Drops, Several Newcomers Move Up

2 May 22

Penny Stocks, Small Cap, Crowdsourcing, Top Stories, Trading Ideas, General

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. Here is a look at the most-searched-for stocks on Benzinga Pro in the month of April.

Sunshine Biopharma Shares See Pre-Market Volatility Following Aegis Capital Press Release Highlighting Aegis Acted As Exclusive Placement Agent On Co.'s $19.5M Private Placement Priced At The Market

28 Apr 22

News, Offerings

NEW YORK, NY / ACCESSWIRE / April 28, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ:SBFM)

71 Biggest Movers From Yesterday

27 Apr 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers

34 Stocks Moving In Tuesday's Mid-Day Session

26 Apr 22

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

60 Biggest Movers From Yesterday

26 Apr 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers

Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide

25 Apr 22

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday.

12 Health Care Stocks Moving In Monday's Intraday Session

25 Apr 22

Intraday Update, Markets, Movers

Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher

25 Apr 22

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday.

34 Stocks Moving In Monday's Mid-Day Session

25 Apr 22

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.

Why Sunshine Biopharma Stock Is Surging

25 Apr 22

News, Penny Stocks, Movers, Trading Ideas

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading higher Monday after the company announced it filed a United States provisional patent application covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points

25 Apr 22

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multi-drug Resistant Cancer Cells

25 Apr 22

News, Legal

Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it hasSunshine Biopharma, Inc.

54 Biggest Movers From Yesterday

20 Apr 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers

5 Stocks Halted In Tuesday's Session

19 Apr 22

Penny Stocks, Small Cap, Trading Ideas

A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to the markets. Here are all the stocks halted on a circuit breaker today, according to Benzinga Pro.

12 Health Care Stocks Moving In Tuesday's Intraday Session

19 Apr 22

Intraday Update, Markets, Movers

EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments

19 Apr 22

Biotech, News, Penny Stocks, Top Stories, Exclusives, Interview, General

Sunshine Biopharma Inc. (NASDAQ: SBFM) might be living the concept of being in the right place at the right time.

38 Stocks Moving In Tuesday's Mid-Day Session

19 Apr 22

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

68 Biggest Movers From Yesterday

19 Apr 22

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions.

51 Biggest Movers From Thursday

18 Apr 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2%

8 Apr 22

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday.

Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market

28 Apr 22

News, Financing, Press Releases

MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW") (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and

Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)

28 Apr 22

News, Press Releases

NEW YORK, NY / ACCESSWIRE / April 28, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ:SBFM)About Sunshine

Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

26 Apr 22

Markets, Press Releases

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW") (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and

Advanced Immunological and Clinical Trials for Treating Ovarian Cancer Accelerating

25 Apr 22

Opinion, Press Releases

PALM BEACH, Fla., April 25, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer remains

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells

25 Apr 22

Press Releases, General

MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW"), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs,

Thinking about buying stock in Aterian, Sonnet BioTherapeutics, Gap, Uranium Energy, or Sunshine Biopharma?

13 Apr 22

Opinion, Press Releases

NEW YORK, April 13, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATER, SONN, GPS, UEC, and SBFM.

Thinking about buying stock in Lixte Biotechnology, Hoth Therapeutics, Ocugen, Bilibili, or Sunshine Biopharma?

12 Apr 22

Small Cap, Opinion, Press Releases

NEW YORK, April 12, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LIXT, HOTH, OCGN, BILI, and SBFM.

Thinking about buying stock in AT&T, Exela Technologies, Iveda Solutions, Bitnile, or Sunshine Biopharma?

11 Apr 22

Small Cap, Opinion, Press Releases

NEW YORK, April 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for T, XELA, IVDA, NILE, and SBFM.

Thinking about buying stock in Sunshine Biopharma, Bitnile, Robinhood Markets, Momentus, or Nordic American Tanker?

8 Apr 22

Opinion, Press Releases

NEW YORK, April 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SBFM, NILE, HOOD, MNTS, and NAT.

BioMed Leaders: Sunshine Biopharma, PharmaDrug, Blue Water Vaccines, and MedAvail; Visionary CEOs Advancing Healthcare, with Vaccines, Cancer Therapeutics, and Affordable Pharmaceuticals

8 Apr 22

News, Press Releases, General

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Sunshine Biopharma, Inc.

Thinking about buying stock in Sunshine Biopharma, IMAC, Advent Technologies, Bitnile, or Rite Aid?

7 Apr 22

Small Cap, Opinion, Press Releases

NEW YORK, April 7, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SBFM, IMAC, ADN, NILE, and RAD.

Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ: SBFM)

15 Mar 22

News, Press Releases

NEW YORK, NY / ACCESSWIRE / March 15, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ:SBFM)About Sunshine Biopharma, Inc.Severe Acute

Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market

14 Mar 22

News, Financing, Press Releases

MONTREAL, March 14, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW") (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and

Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market

10 Mar 22

News, Health Care, Financing, Press Releases

MONTREAL, March 10, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: "SBFM" and "SBFMW") (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and

Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The University Of Arizona

25 Feb 22

Health Care, Press Releases

MONTREAL, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: "SBFM" and SBFMW) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company focused on the research, development and